This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Deutsche Bank analyst Bryan Keane downgraded the rating for Marqeta, Inc. MQ from Buy to Hold and lowered the price target from $9 to $4. Marqeta shares closed at $5.95 on Monday. See how other analysts view this stock.
Truist Securities analyst Jamie Cook downgraded Cognex Corporation CGNX from Buy to Hold and slashed the price target from $46 to $43. Cognex shares closed at $40.85 on Monday. See how other analysts view this stock.
JMP Securities analyst Reni Benjamin downgraded the rating for Sana Biotechnology, Inc. SANA from Market Outperform to Market Perform. Sana Biotechnology shares closed at $3.76 on Monday. See how other analysts view this stock.
JP Morgan analyst Tessa Romero downgraded Neumora Therapeutics, Inc. NMRA from Overweight to Neutral and lowered the price target from $18 to $15. Neumora Therapeutics shares closed at $11.71 on Monday. See how other analysts view this stock.
Leerink Partners analyst Christopher Liu downgraded the rating for IDEAYA Biosciences, Inc. IDYA from Outperform to Market Perform and lowered the price target from $41 to $27. IDEAYA Biosciences shares closed at $30.00 on Monday. See how other analysts view this stock.